Investing.com - Merck&Co (NYSE:MRK) reported first quarter earnings that Beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $1.22 on revenue of $10.82B. Analysts polled by Investing.com anticipated EPS of $1.05 on revenue of $10.47B. That compared to EPS of $1.05 on revenue of $10.04B in the same period a year earlier. The company had reported EPS of $1.04 on revenue of $11B in the previous quarter.
Merck&Co follows other major Healthcare sector earnings this month
On April 16, J&J reported first quarter EPS of $2.1 on revenue of $20.02B, compared to forecasts of EPS of $2.04 on revenue of $19.61B.
Pfizer earnings Beat analysts' expectations on Tuesday, with first quarter EPS of $0.85 on revenue of $13.12B. Investing.com analysts expected EPS of $0.75 on revenue of $13B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar